[go: up one dir, main page]

NO20080417L - Benzosykloheptapyridiner som inhibitorer av reseptortyrosinkinasen MET - Google Patents

Benzosykloheptapyridiner som inhibitorer av reseptortyrosinkinasen MET

Info

Publication number
NO20080417L
NO20080417L NO20080417A NO20080417A NO20080417L NO 20080417 L NO20080417 L NO 20080417L NO 20080417 A NO20080417 A NO 20080417A NO 20080417 A NO20080417 A NO 20080417A NO 20080417 L NO20080417 L NO 20080417L
Authority
NO
Norway
Prior art keywords
tyrosine kinase
receptor tyrosine
benzocycloheptapyridines
inhibitors
kinase met
Prior art date
Application number
NO20080417A
Other languages
English (en)
Inventor
James P Jewell
Jonathan R Young
Christopher J Dinsmore
Jason D Katz
Michelle R Machacek
Ryan D Otte
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO20080417L publication Critical patent/NO20080417L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse vedrører 5H-benzo[4,5]syklohepta[1,2-b]pyridinderivater som er anvendbare til behandling av cellulære proliferative sykdommer, til behandling av forstyrrelser forbundet med MET-aktivitet, og til inhibering av reseptortyrosinkinasen MET. Oppfinnelsen vedrører også preparater som omfatter disse forbindelsene, og fremgangsmåter for anvendelse av dem til å behandle kreft hos pattedyr.
NO20080417A 2005-06-23 2008-01-22 Benzosykloheptapyridiner som inhibitorer av reseptortyrosinkinasen MET NO20080417L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69322905P 2005-06-23 2005-06-23
US72906105P 2005-10-21 2005-10-21
US78947306P 2006-04-05 2006-04-05
PCT/US2006/024256 WO2007002258A2 (en) 2005-06-23 2006-06-22 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met

Publications (1)

Publication Number Publication Date
NO20080417L true NO20080417L (no) 2008-03-18

Family

ID=37595817

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080417A NO20080417L (no) 2005-06-23 2008-01-22 Benzosykloheptapyridiner som inhibitorer av reseptortyrosinkinasen MET

Country Status (21)

Country Link
EP (1) EP1896422B1 (no)
KR (1) KR20080018907A (no)
AR (1) AR057377A1 (no)
AT (1) ATE520664T1 (no)
BR (1) BRPI0612518A2 (no)
CR (1) CR9579A (no)
CY (1) CY1112038T1 (no)
DO (1) DOP2006000143A (no)
EC (1) ECSP078017A (no)
IL (1) IL187895A0 (no)
MA (1) MA29643B1 (no)
MX (1) MX2007016533A (no)
NI (1) NI200700318A (no)
NO (1) NO20080417L (no)
NZ (1) NZ563711A (no)
PE (1) PE20070167A1 (no)
PL (1) PL1896422T3 (no)
PT (1) PT1896422E (no)
SI (1) SI1896422T1 (no)
TW (1) TW200738638A (no)
WO (1) WO2007002258A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200813021A (en) 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
US7893081B2 (en) * 2007-12-20 2011-02-22 Merck & Co., Inc. Tyrosine kinase inhibitors
US8674105B2 (en) 2009-09-30 2014-03-18 Merck Sharp & Dohme Limited Crystalline hydrochloride salts of c-Met kinase inhibitors
EP2482803B1 (en) 2009-09-30 2021-12-22 Merck Sharp & Dohme (UK) Limited Formulations for c-met kinase inhibitors
US20130315895A1 (en) 2010-07-01 2013-11-28 Takeda Pharmaceutical Company Limited COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
ES2764299T3 (es) 2014-12-09 2020-06-02 Inst Nat Sante Rech Med Anticuerpos monoclonales humanos contra AXL
WO2016135041A1 (en) 2015-02-26 2016-09-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Fusion proteins and antibodies comprising thereof for promoting apoptosis
AU2020242287A1 (en) 2019-03-21 2021-09-02 INSERM (Institut National de la Santé et de la Recherche Médicale) A Dbait molecule in combination with kinase inhibitor for the treatment of cancer
KR20220098759A (ko) 2019-11-08 2022-07-12 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 키나제 억제제에 대해 내성을 획득한 암의 치료 방법
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1427706B1 (en) * 2001-09-19 2007-05-30 Pharmacia Corporation Substituted pyrazolo compounds for the treatment of inflammation
AU2003230758A1 (en) * 2002-04-02 2003-10-20 Merck And Co., Inc. 5h-benzo(4,5)cyclohepta(1,2-b)pyridine nmda/nr2b antagonists

Also Published As

Publication number Publication date
ECSP078017A (es) 2008-01-23
IL187895A0 (en) 2008-03-20
MX2007016533A (es) 2008-03-06
BRPI0612518A2 (pt) 2010-11-23
EP1896422A2 (en) 2008-03-12
PL1896422T3 (pl) 2012-01-31
CR9579A (es) 2008-03-06
SI1896422T1 (sl) 2011-11-30
KR20080018907A (ko) 2008-02-28
PT1896422E (pt) 2011-11-08
AR057377A1 (es) 2007-11-28
MA29643B1 (fr) 2008-07-01
EP1896422B1 (en) 2011-08-17
WO2007002258A3 (en) 2007-06-07
NZ563711A (en) 2010-12-24
NI200700318A (es) 2008-05-23
DOP2006000143A (es) 2007-02-28
CY1112038T1 (el) 2015-11-04
ATE520664T1 (de) 2011-09-15
PE20070167A1 (es) 2007-04-16
TW200738638A (en) 2007-10-16
WO2007002258A2 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
NO20080417L (no) Benzosykloheptapyridiner som inhibitorer av reseptortyrosinkinasen MET
NO20090608L (no) Tyrosinkinaseinhibitorer
DK1896421T3 (da) Benzocyclohetapyridiner som hæmmere af receptoren tyrosinkinase MET
NO20076659L (no) Pyrrolo(2,3-B)pyridinderivater som protein kinase inhibitorer
NO20084496L (no) Pyridyl- og pyrimidinylsubstituerte pyrrol-, tiofen- og furanderivater som kinaseinhibitorer
WO2007149427A3 (en) Tyrosine kinase inhibitors
NO20070506L (no) Fremgangsmater og mellomprodukter nyttige for fremstilling av kondenserte heterocykliske kinase inhibitorer.
NO20080162L (no) Tienopyrimidin og tienopyrimidinderivater som FLT-3 kinaseinhibitorer
MY148851A (en) Dihydropyridine derivatives as useful as protein kinase inhibitors
NO20061194L (no) Mitotiske kinesininbibitorer
TW200407311A (en) N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
UA98449C2 (en) Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
TW200633980A (en) Pyridones useful as inhibitors of kinases
MX2009006700A (es) Derivados de 5-ciano-4-(pirolo)[2,3b]piridina-3-il)-pirimidinas utiles como inhibidores de proteina-cinasas.
NO20023831L (no) Pyrrol substituert 2-indolinonproteinkinaseinhibitorer
NO20082508L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
DK1791830T3 (da) Diaminotriazol-forbindelser der er nyttige som protein-kinase-inhibitorer
NO20080168L (no) Aminoquinolin- og aminoquinoazolinkinasemodulatorer
NO20065727L (no) Pyrrolinhibitorer av erk-proteinkinase, syntese derav og deres mellomprodukter
NO20080174L (no) Alkylquinolin- og alkylquinazolinkinasemodulatorer
WO2006124354A3 (en) Tyrosine kinase inhibitors
NO20080161L (no) Aminopyrimidiner som kinasemodulatorer
NO20092130L (no) Tricykliske heteroarylforbindelser anvendelige som inhibitorer of januskinase
MX2010003563A (es) Inhibidores de proteina cinasa de c-met.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application